Chandigarh, Jan 12: Shivtek Spechemi Industries Ltd, the leading specialty chemicals manufacturer and flagship company of the Shiva Group of Industries, has announced the appointment of Dr. Trusar D. Bagul as an Independent Director to its Board. Holding a PhD in Organic Chemistry from the National Chemical Laboratory (NCL), Pune, Dr. Bagul brings a rare combination of profound academic research and industrial expertise to the board. The strategic appointment is part of Shivtek’s continued focus on strengthening governance, deepening technical oversight, and supporting its long-term growth and innovation roadmap.
With close to three decades of experience in chemistry research and management spanning across Drug Discovery, Pharmaceutical, Fine Chemical, and Specialty Chemical segments, Dr. Bagul brings deep scientific acumen combined with strong business and operational insight. A prolific researcher with multiple international scientific publications, U.S. and Indian patents to his credit, Dr. Bagul has a proven track record of leading the research and operation teams in bridging the gap between complex synthetic chemistry and commercial business viability. His expertise in “High Value – Low Volume” projects and cost-effective chemical development is expected to be a cornerstone for Shivtek’s upcoming R&D initiatives.
Commenting on the appointment, Mr. Amitt Nenwani, Managing Director, Shivtek Spechemi Industries Ltd, said, “We are delighted to welcome Trusar D. Bagul to our Board. As Shivtek embarks on an expansion journey aimed at reinforcing India’s self-reliance in the chemical sector through green manufacturing and advanced import-substitution products, Trusar’s profound expertise and scientific advisory will be invaluable. This appointment reinforces our commitment to strong governance and informed decision-making as we pursue our long-term vision.”
As an Independent Director, Dr. Bagul will be responsible for helping Shivtek’s research and development team. Dr. Bagul’s appointment is designed to provide the board with deep technical oversight as the company navigates the complex, technology-driven expansions.
Speaking on his appointment, Dr. Trusar D. Bagul, Independent Director, Shivtek Spechemi Industries Ltd, said,“I am delighted to join Shivtek Spechemi Industries Ltd at a pivotal stage of their growth. Their commitment to sustainability, quality and global growth strongly resonate with my professional values and I look forward to working with the Board and management to support the company’s strategic priorities and contribute towards its goal of becoming a global hub for green specialty chemistry.”
Dr. Bagul is an accomplished organic and medicinal chemist with extensive experience across drug discovery, fine chemicals, pharmaceutical intermediates, and chemistry services. Over the course of his career, he has held several senior leadership positions at chemistry-focused enterprises, working closely with global pharmaceutical and biotech clients. He is also an entrepreneur and currently provides scientific and strategic advisory services to pharma, biopharma, and chemical companies.
He has undertaken post-doctoral research at Kyoto University, Japan, where his work has been published in reputed international journals. Dr. Bagul is a recipient of prestigious fellowships including the Japan Society for Promotion of Science (JSPS) fellowship and has several international and Indian patents to his credit.